Trademark: 87771644
Status Date
Friday, April 1, 2022
Filing Date
Friday, January 26, 2018
Abandoned Date
Wednesday, March 16, 2022
41 Providing online non-downloadable electronic publications in the nature of newsletters, journals, and books in the field of cannabinoid-based medicines; arranging, conducting and organisation of educational conferences, congresses, seminars and symposiums in the field of cannabinoid-based medicines; information, advisory and consultancy services in relation to all of the aforesaid services
36 Financing services; providing funding for investigators, inventors, universities, research institutes and other academic entities, namely, financing services and providing venture capital, development capital, private equity and investment funding; funding of research and product development, namely, financing services and providing venture capital, development capital, private equity and investment funding; information, advisory and consultancy services in relation to all of the aforesaid services
42 Scientific and technological services and research and design relating thereto, namely, scientific research in the field of cannabinoid-based medicines, research on the subject of pharmaceuticals, and pharmaceutical drug development services, all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; pharmaceutical research and development services all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; research, testing and development of pharmaceutical and veterinary preparations all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; biological, clinical and medical research all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; conducting clinical trials for others all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; chemical analysis all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; information, advisory and consultancy services in relation to all of the aforesaid services
Apr 1, 2022
Abandonment Notice E-Mailed - Failure To Respond
Apr 1, 2022
Abandonment - Failure To Respond Or Late Response
Sep 15, 2021
Teas Change Of Correspondence Received
Sep 15, 2021
Teas Change Of Domestic Representatives Address
Sep 15, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 15, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 15, 2021
Notification Of Non-Final Action E-Mailed
Sep 15, 2021
Non-Final Action E-Mailed
Sep 15, 2021
Non-Final Action Written
Aug 18, 2021
Suspension Checked - To Attorney For Action
Jul 28, 2021
Assignment Of Ownership Not Updated Automatically
Nov 23, 2020
Report Completed Suspension Check Case Still Suspended
May 6, 2020
Report Completed Suspension Check Case Still Suspended
Apr 20, 2020
Suspension Checked - To Attorney For Action
Oct 11, 2019
Report Completed Suspension Check Case Still Suspended
Apr 17, 2019
Automatic Update Of Assignment Of Ownership
Apr 11, 2019
Notification Of Letter Of Suspension E-Mailed
Apr 11, 2019
Letter Of Suspension E-Mailed
Apr 11, 2019
Suspension Letter Written
Mar 11, 2019
Assigned To Examiner
Feb 11, 2019
Assigned To Examiner
Feb 5, 2019
Teas/Email Correspondence Entered
Feb 5, 2019
Correspondence Received In Law Office
Jan 28, 2019
Assigned To Lie
Jan 21, 2019
Teas Response To Office Action Received
Jul 23, 2018
Notification Of Non-Final Action E-Mailed
Jul 23, 2018
Non-Final Action E-Mailed
Jul 23, 2018
Non-Final Action Written
Jul 23, 2018
Assigned To Examiner
May 10, 2018
Assigned To Examiner
May 9, 2018
Assigned To Examiner
Feb 7, 2018
New Application Office Supplied Data Entered
Jan 30, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
